Mode
Text Size
Log in / Sign up
N/A N=92 Diagnostic

Determinants of Age Related Breathing Instability During Non-Rapid-Eye-Movement (NREM) Sleep

Sleep Apnea · Age

Enrolled (actual)
92
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Apneic Threshold (AT) and Carbon-dioxide (CO2) Reserve — 39.8; 36.7; -4.1; -2.6 mm Hg — p=<0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
1) hyperventilation via noninvasive positive pressure ventilation 2) multiple trials of episodic hypoxia (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Apr 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Apneic Threshold (AT) and Carbon-dioxide (CO2) Reserve
39.8; 36.7; -4.1; -2.6 <0.05 sig
PRIMARY
Long-term Facilitation (LTF) of Ventilation, Minute Ventilation Was Measured in Older Adults Only
94.4 <0.05 sig
SECONDARY
Hypoxic Ventilatory Response
0.21; 0.53 <0.05 sig
SECONDARY
Brief Hyperoxia Response
89.7; 79.6 <0.05 sig

Summary

The purpose for this research protocol was to examine the role of breathing control mechanisms that determine the development of sleep-disordered breathing in the elderly. This proposal focused on key factors that contribute to the control of ventilation in elderly adults during sleep. The investigators studied the age-specific changes in ventilatory control in older and young adults during NREM sleep.

Eligibility Criteria

Inclusion Criteria

  • Healthy older and young adults

Exclusion Criteria

  • Pregnancy,
  • history of active coronary artery disease-including stable and unstable angina,
  • recent myocardial infarction,
  • history of congestive heart failure,
  • stroke,
  • excessive daytime sleepiness with Epworth Sleepiness Scale of >15
  • patient with OSA- (Obstructive sleep apnea) on therapy
  • depression,
  • schizophrenia,
  • untreated hypothyroidism,
  • diabetes on insulin,
  • seizure disorder,
  • intrinsic renal and liver disorders,
  • failure to give informed consent,
  • patients with evidence of pulmonary diseases based on history and abnormal pulmonary function testing, including obstructive (ratio of predicted forced expiratory volume to forced vital capacity, 34kg/m2
  • subjects with sleep apnea are already using continuous positive airway pressure for more than 7 days as therapy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00732199). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search